Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Yushi Nakai"'
Autor:
Hiroshi Sakai, Yukito Ichinose, Masaaki Kawahara, Takahiko Sugiura, Kozo Yoshimori, Yushi Nakai, Hisanobu Niitani
Publikováno v:
Clinical Cancer Research. 10:7860-7864
Purpose: To evaluate the efficacy and toxicity of a novel combination chemotherapeutic regimen including cisplatin with an oral anticancer agent, S-1 that consisted of tegafur, 5-chloro-2, 4-dihydroxypyridine, and potassium oxonate, for non–small-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fc26aeae015fcac073caac53b1f8657
https://doi.org/10.1158/1078-0432.ccr-04-1200
https://doi.org/10.1158/1078-0432.ccr-04-1200
Autor:
Toshihiro Nukiwa, Shoji Kudoh, Yushi Nakai, Hisanobu Niitani, Hiroshi Semba, Susumu Yoshida, Hidehiko Yamamoto, Yukito Ichinose, Yoshio Yamane
Publikováno v:
Clinical Cancer Research. 10:4369-4373
Purpose: To evaluate the efficacy and toxicity of a novel combination treatment using concurrent radiotherapy with cisplatin plus UFT, which is comprised of uracil and tegafur, in locally advanced non-small cell lung cancer (NSCLC) patients. Experime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9cc4908b8ed2d301e412f1509ad097c
https://doi.org/10.1158/1078-0432.ccr-04-0143
https://doi.org/10.1158/1078-0432.ccr-04-0143
Autor:
Osamu Ishimoto, Masahito Ebina, Toshihiro Nukiwa, Noboru Asou, Yushi Nakai, Nobumichi Matsubara, Yasuo Saijo, Ko Narumi, Yuichiro Kimura
Publikováno v:
Oncology. 63:70-75
Angiogenic cytokines, such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and angiogenin, are candidates for the induction of pleural effusions because they have been implicated in the induction of neovascularizat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e16acae31801061307fb78856ed04d39
https://doi.org/10.1159/000065723
https://doi.org/10.1159/000065723
Autor:
Yutaka Yamaguchi, Mitsuo Ohta, Masahiro Fukuoka, Yushi Nakai, Kiyoyuki Furuse, Mitsuo Asakawa, Hisanobu Niitani, Kiyokazu Yoshida, Masafumi Fujii
Publikováno v:
Acta Oncologica. 33:523-526
Oral BOF-A2 (Emitefur), a new derivative of 5-fluorouracil (5-FU) containing both 1-ethoxymethyl-5-FU (EMFU), a masked form of 5-FU, and 3-cyano-2,6-dihydroxypyridine (CNDP), an inhibitor of 5-FU degradation, was administered to 71 non-small cell lun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98364f67298d5be770ce6ff431941fa5
https://doi.org/10.3109/02841869409083929
https://doi.org/10.3109/02841869409083929
Autor:
Yuka Numata, Shunichi Sugawara, Yasuo Saijo, Junichi Saito, Yushi Nakai, Shuji Suzuki, Masakichi Motomiya
Publikováno v:
Chemotherapy. 38:281-285
Serial serum erythropoietin (EPO) levels were measured in 12 adult lung cancer patients during cancer chemotherapy. In major cases, EPO levels increased significantly after chemotherapy while the hemoglobin (Hb) remained at initial levels. EPO fell g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f0371d0dafa6f1466920f3005027ee8
https://doi.org/10.1159/000239014
https://doi.org/10.1159/000239014
Autor:
Yukito, Ichinose, Kozo, Yoshimori, Hiroshi, Sakai, Yushi, Nakai, Takahiko, Sugiura, Masaaki, Kawahara, Hisanobu, Niitani
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 10(23)
To evaluate the efficacy and toxicity of a novel combination chemotherapeutic regimen including cisplatin with an oral anticancer agent, S-1 that consisted of tegafur, 5-chloro-2, 4-dihydroxypyridine, and potassium oxonate, for non-small-cell lung ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1cd71badbaefb93d5f81cbc8fbddb4cc
https://pubmed.ncbi.nlm.nih.gov/15585618
https://pubmed.ncbi.nlm.nih.gov/15585618
Autor:
Yukito, Ichinose, Yushi, Nakai, Shoji, Kudoh, Hiroshi, Semba, Susumu, Yoshida, Toshihiro, Nukiwa, Hidehiko, Yamamoto, Yoshio, Yamane, Hisanobu, Niitani
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 10(13)
To evaluate the efficacy and toxicity of a novel combination treatment using concurrent radiotherapy with cisplatin plus UFT, which is comprised of uracil and tegafur, in locally advanced non-small cell lung cancer (NSCLC) patients.In this Phase II t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae6a5c459b291edd3347fc424ae866c7
https://pubmed.ncbi.nlm.nih.gov/15240524
https://pubmed.ncbi.nlm.nih.gov/15240524
Autor:
Syuichi Yoneda, Koshiro Watanabe, Kazumasa Noda, Yuka Fujita, Yuzo Kurita, Akira Yokoyama, Hisanobu Niitani, Hiroshi Kunikane, Yushi Nakai
Publikováno v:
International journal of clinical oncology. 6(6)
Background. It has been reported that the combination of gemcitabine (LY188011; GEM) and cisplatin (CDDP) in a 4-week schedule showed a high response rate for patients with non-small-cell lung cancer (NSCLC), but GEM could not be administered on day
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f912b647d64ec9814b9b5ed554392fdc
https://pubmed.ncbi.nlm.nih.gov/11828947
https://pubmed.ncbi.nlm.nih.gov/11828947
Autor:
Yoshio Yamane, Junichi Saito, Yasuo Saijo, Yushi Nakai, Tomei Tsukamoto, Tsuneo Sayama, Sadahiro Koinumaru, Noboru Aso, Takehito Nakabayashi, Toshihiro Nukiwa, Yoshifumi Matsuura
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 31(2-3)
Based on the results of our previous pilot study, we conducted a multi-institutional phase II study of combination chemotherapy consisting of oral UFT (Taiho Pharmaceutical Co. Ltd, Tokyo) plus cisplatin (CDDP) in patients with advanced non-small cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::515363c52e3f11a299bc373a3b53e35c
https://pubmed.ncbi.nlm.nih.gov/11165409
https://pubmed.ncbi.nlm.nih.gov/11165409
Autor:
Hiroshi Takahashi, Afzalunnesa Binte Lutfor, Yoshihiro Honda, Saforu Shoji, Toshihiro Nukiwa, Yushi Nakai, Yutaka Tokue, Kikuchi H, Tohru Kikuchi, Akira Watanabe, Shigeru Fujimura
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 5(3)
We investigated the antibacterial activity of 12 antibiotics, including 4 carbapenems, against 200 strains of respiratory pathogens isolated in 1997, and compared the results with those obtained in 1993. The strains examined were 38 strains of methic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d45c24cf3f71d4e9b8b75ba208d7079
https://pubmed.ncbi.nlm.nih.gov/11810511
https://pubmed.ncbi.nlm.nih.gov/11810511